Antibiotic-resistant “superbugs” that can defeat efforts to kill them are an urgent public health crisis, and according to the Centers for Disease Control, more than 2.8 million antibiotic-resistant infections occur each year.
Apellis shares tumble on reports of eye inflammation in patients taking Syfovre
Apellis Pharmaceuticals took a 21% hit to its stock price $APLS on Monday morning, wiping $2 billion from its market cap after a group of
July 18, 2023